Your personalized program may include nutrition coaching, medically supervised GLP-1 medication, lifestyle support, and ongoing in-clinic care designed to improve hunger signals, metabolic function, energy levels, and long-term results
Your options include Ozempic or Wegovy injections or oral Rybelsus, provided your provider prescribes them
The medication is available in two formulations: Ozempic (approved for type 2 diabetes at doses up to 2.0 mg weekly, not FDA-approved for weight management) and Wegovy (approved specifically for weight management at doses up to 2.4 mg weekly, with a recommended dose escalation schedule starting at 0.25 mg and increasing gradually to minimize side effects)
We randomly assigned patients to two groups using an Excel (Microsoft Corp., Redmond, WA, USA)-based allocation system with stratification and 1:1 allocation via permuted-block randomization
None of these are safe to inject